News
Absence of neurotoxicity of any grade in low-volume disease to-date – – On track for first Biologics License Application (BLA) approved cell therapy in orphan indication relapsed/refractory AL ...
Eli Lilly reported impressive data at the recent American Diabetes Association ('ADA') conference. Its robust pipeline will ...
Werewolf Therapeutics, Inc. (the 'Company” or 'Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering ...
Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...
To Bentley’s design centre, so new that the paint has barely dried, to experience something of a landmark: the conceptual ...
Samsung Electronics Co. introduced three new foldable smartphones in an effort to broaden mainstream appeal before Apple Inc.
Samsung opens pre-bookings for Galaxy Z 7 series. Sony WF-C710N earbuds launched. Amazfit Active 2 Square smartwatch. JBL ...
Q4 2025 Earnings Call Transcript July 8, 2025 Aehr Test Systems beats earnings expectations. Reported EPS is $-0.01, ...
Transaction Expected to be Accretive to Long-Term EPS Growth Rate; Texas Projected to Become Second Largest Utility Operation of H2O America by 20281 Company to Host Investor Webcast Today at 5:30 a.m ...
The main Department of Justice building, across from the National Archives in Washington, was the kind of brooding edifice ...
As Consumers Search for the Best Non-Prescription Eye Supplements in 2025, Visium Pro Highlights Clean Label Formulation, GMP ...
(73%) enrolled in the 180mg Q8W open label extension study achieved a complete response at 12 weeks Results from the 240mg Q8W and the 240mg followed by 180mg Q8W cohorts appear to be confounded by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results